↓ Skip to main content

PLOS

The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review

Overview of attention for article published in PLOS ONE, January 2013
Altmetric Badge

Mentioned by

policy
1 policy source
twitter
1 X user
patent
1 patent

Readers on

mendeley
51 Mendeley
Title
The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
Published in
PLOS ONE, January 2013
DOI 10.1371/journal.pone.0051780
Pubmed ID
Authors

Limor Amit, Irit Ben-Aharon, Liat Vidal, Leonard Leibovici, Salomon Stemmer

Abstract

To evaluate the effect of Bevacizumab in combination with chemotherapy on overall survival of patients with metastatic solid tumors.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 51 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 24%
Other 6 12%
Student > Ph. D. Student 6 12%
Student > Bachelor 5 10%
Student > Postgraduate 4 8%
Other 10 20%
Unknown 8 16%
Readers by discipline Count As %
Medicine and Dentistry 24 47%
Agricultural and Biological Sciences 4 8%
Biochemistry, Genetics and Molecular Biology 3 6%
Nursing and Health Professions 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 5 10%
Unknown 12 24%